Our partner is focused on discovering and developing transformative therapies for a range of diseases, with an emphasis on oncology and autoimmune conditions. Their approach combines advanced science and innovative technologies to address unmet medical needs and improve patient outcomes.

This senior leader was responsible for developing regulatory strategies for small molecules, biologics, and novel therapies for multiple indications. This included the evaluation of regulatory risks/gaps and developing contingency plans for overall early development programs with a focus on efficient global planning for first-in-human and proof-of-concept studies.